The company offers research services to the pharmaceutical industry, focusing on designing and executing client studies in areas such as metabolic syndrome, obesity, diabetes, cardiovascular, renal (including polycystic kidney disease), and neurology. PreClinOmics, Inc. specializes in analytical services and research of cardiovascular, metabolic and renal diseases, providing clients with high-quality data to support their drug development programs. With their expertise in in vivo preclinical research, the company is dedicated to advancing the understanding of disease mechanisms and developing effective treatments for patients.